Literature DB >> 2492308

Interaction of Neisseria gonorrhoeae with classical complement components, C1-inhibitor, and a monoclonal antibody directed against the Neisserial H.8 antigen.

J E Schweinle1, P J Hitchcock, A J Tenner, C H Hammer, M M Frank, K A Joiner.   

Abstract

Strains of Neisseria gonorrhoeae were used to evaluate bactericidal and opsonic properties of McAb 10 directed against the Neisserial outer membrane antigen, H.8. Gonococci were either serum resistant in the absence but serum sensitive in the presence, of McAb 10, or serum sensitive or serum resistant regardless of the presence of McAb 10. Strain JS3, which fell in the former category, was used in subsequent studies. C1 zymogen formed by reassociation of isolated C1 subunits was not directly activated by JS3 in the presence or absence of C1-inhibitor. JS3 thus was unable to directly activate the classical pathway independently of antibody. When purified classical pathway components were used to deposit C3 on JS3 in the absence of serum regulatory proteins or antibodies, added C1-inhibitor reduced C3 binding to background levels. When McAb 10 was present, C3 binding was unaffected by C1-inhibitor. Covalently bound, large molecular weight C3 alpha-chain-gonococcal complexes were disbanded by methylamine release of ester linkages. Released 125I-C3 migrated as C3b without degradation by gonococcal proteases. Purified classical components alone or McAb 10 alone facilitated JS3 killing by neutrophils; when combined, the two provided maximal killing. Levels of McAb 10 that only slightly increase C3 deposition on JS3 are bactericidal in serum and maximally opsonic in combination with purified classical pathway components.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2492308      PMCID: PMC303694          DOI: 10.1172/JCI113897

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  46 in total

1.  Monoclonal antibodies directed against gonococcal protein I vary in bactericidal activity.

Authors:  K A Joiner; K A Warren; M Tam; M M Frank
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

Review 2.  The classical complement pathway: activation and regulation of the first complement component.

Authors:  N R Cooper
Journal:  Adv Immunol       Date:  1985       Impact factor: 3.543

3.  Antibody-independent C1 activation by E. coli.

Authors:  A J Tenner; R J Ziccardi; N R Cooper
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

4.  Studies on the mechanism of bacterial resistance to complement-mediated killing. IV. C5b-9 forms high molecular weight complexes with bacterial outer membrane constituents on serum-resistant but not on serum-sensitive Neisseria gonorrhoeae.

Authors:  K A Joiner; K A Warren; E J Brown; J Swanson; M M Frank
Journal:  J Immunol       Date:  1983-09       Impact factor: 5.422

5.  Antibody-independent activation of C1, the first component of complement, by cardiolipin.

Authors:  T Kovacsovics; J Tschopp; A Kress; H Isliker
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

6.  Monoclonal antibody that recognizes an outer membrane antigen common to the pathogenic Neisseria species but not to most nonpathogenic Neisseria species.

Authors:  J G Cannon; W J Black; I Nachamkin; P W Stewart
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

7.  Serum sensitivity of Neisseria gonorrhoeae: the role of lipopolysaccharide.

Authors:  W M Shafer; K Joiner; L F Guymon; M S Cohen; P F Sparling
Journal:  J Infect Dis       Date:  1984-02       Impact factor: 5.226

Review 8.  The first component of human complement (C1): activation and control.

Authors:  R J Ziccardi
Journal:  Springer Semin Immunopathol       Date:  1983

9.  Neisserial antigen H.8 is immunogenic in patients with disseminated gonococcal and meningococcal infections.

Authors:  J R Black; W J Black; J G Cannon
Journal:  J Infect Dis       Date:  1985-04       Impact factor: 5.226

10.  Bactericidal but not nonbactericidal C5b-9 is associated with distinctive outer membrane proteins in Neisseria gonorrhoeae.

Authors:  K A Joiner; K A Warren; C Hammer; M M Frank
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

View more
  4 in total

Review 1.  Neisseria gonorrhoeae host adaptation and pathogenesis.

Authors:  Sarah Jane Quillin; H Steven Seifert
Journal:  Nat Rev Microbiol       Date:  2018-02-12       Impact factor: 60.633

2.  Human mannose-binding protein activates the alternative complement pathway and enhances serum bactericidal activity on a mannose-rich isolate of Salmonella.

Authors:  J E Schweinle; R A Ezekowitz; A J Tenner; M Kuhlman; K A Joiner
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

Review 3.  Utilizing complement evasion strategies to design complement-based antibacterial immunotherapeutics: Lessons from the pathogenic Neisseriae.

Authors:  Sanjay Ram; Jutamas Shaughnessy; Rosane B DeOliveira; Lisa A Lewis; Sunita Gulati; Peter A Rice
Journal:  Immunobiology       Date:  2016-06-01       Impact factor: 3.144

4.  A New Tool for Complement Research: In vitro Reconstituted Human Classical Complement Pathway.

Authors:  Michele Mutti; Katharina Ramoni; Gábor Nagy; Eszter Nagy; Valéria Szijártó
Journal:  Front Immunol       Date:  2018-12-04       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.